COMMENTARY: Review: Available evidence does not support a benefit for thyroid hormone replacement in adult with subclinical hypothyroidism

Gharib, Hossein
January 2008
ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p6
Academic Journal
The author comments on the study that does not support a benefit of thyroid hormone replacement therapy for subclinical hypothyroidism. He pointed out that the finding is premature enough to consider that the subclinical hypothyroidism should not be treated with thyroid replacement therapy. He asserts that the presented evidence is not sufficient to prove or disprove that treatment is beneficial.


Related Articles

  • Review: Available evidence does not support a benefit for thyroid hormone replacement in adult with subclinical hypothyroidism.  // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p6 

    The article presents a clinical study that evaluates the effect of thyroid hormone replacement on cardiovascular morality and morbidity, symptoms and quality of life in adults with subclinical hypothyroidism. A randomized controlled trials of thyroid hormone replacement were conducted on adult...

  • Are your hypothyroidism patients getting too much thyroid hormone?  // Modern Medicine;Apr96, Vol. 64 Issue 4, p49 

    Presents an abstract of the article entitled `Excessive thyroid hormone replacement therapy,' by J. Nuovo, A. Ellsworth, D.B. Christensen, et al. which was published in the November-December 1995 issue of the `Journal of American Board Family Practice.'

  • Treating Nonthyroidal Illness Syndrome in the Critically Ill Patient: Still a Matter of Controversy. Bello, G.; Paliani, G.; Annetta, M. G.; Pontecorvi, A.; Antonelli, M. // Current Drug Targets;Aug2009, Vol. 10 Issue 8, p778 

    The nonthyroidal illness syndrome (NTIS) is a clinical condition of abnormal thyroid function tests observed in patients with acute or chronic systemic illnesses. The laboratory parameters of NTIS usually include low serum levels of triiodothyronine, with normal or low levels of thyroxine and...

  • Subclinical Hypothyroidism and Lipid Abnormalities in Older women Attending a Vascular Disease Prevention Clinic: Effect of Thyroid Replacement Therapy. Ganotakis, Emmanouil S.; Mandalaki, Kiriaki; Tampakaki, Maria; Malliaraki, Niki; Mandalakis, Emmanouil; Vrentzos, George; Melissas, John; Castanas, Elias // Angiology;Sep/Oct2003, Vol. 54 Issue 5, p569 

    The authors evaluated the frequency and type of lipid disorders associated with subclinical hypothyroidism (SH) in older women referred to their university vascular disease prevention clinic. They also assessed the results of thyroid replacement therapy. Fasting serum lipid profiles and thyroid...

  • Patients with hypothyroidism require regular assessment to ensure optimal thyroid stimulating hormone levels. Adis International Limited // Drugs & Therapy Perspectives;Aug2005, Vol. 21 Issue 8, p6 

    Focuses on the importance of regular assessment and maintenance of optimal levothyroxine sodium dose in primary hypothyroidism treatment. Benefits from thyroid hormone replacement therapy; Thyroid hormone preparations for treating the hypothyroidism; Basis of calculating for the optimal daily...

  • An update on hyper- and hypothyroidism for the pharmacist. Souter, Jacqui // South African Pharmaceutical Journal;2012, Vol. 79 Issue 4, p40 

    Thyroid hormones are responsible for normal growth and development, and the maintenance of metabolic processes. Hyperthyroidism (excess thyroid hormone production) and hypothyroidism (deficiency in the production of thyroid hormone) are common conditions. This article gives a brief overview of...

  • Thyroid hormone use and bone density in men.  // American Family Physician;3/1/1996, Vol. 53 Issue 4, p1350 

    Reports on a study published in the 1995 issue of the `Archives of Internal Medicine' periodical by Schneider et al who evaluated the effect of thyroid hormone replacement therapy in a community-based sample of elderly men. Methodology of the study; Research design; Indications that thyroid...

  • Correction: History and Future of Treatment of Hypothyroidism.  // Annals of Internal Medicine;3/1/2016, Vol. 164 Issue 5, p376 

    There is an error in a recent article. The last sentence of the section titled "L-Thyroxine Monotherapy Fails to Restore All Markers of Hypothyroidism" should read "new technology is needed to allow for steady delivery of L-triiodothyronine" (it currently reads "… for steady delivery of...

  • Evolution of Height and Bone Age in Primary Congenital Hypothyroidism. de Frias, E. Casado; Ruibal, J. L.; Reverte, F.; Bueno, G. // Clinical Pediatrics;Jul1993, Vol. 32 Issue 7, p426 

    Thyroid hormones are fundamental for growth and bone maturity Retarded physical and osseous development signals congenital hypothyroidism. This study assessed the evolution of height and bone age and final height after hormone replacement treatment in 25 patients with primary congenital...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics